Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo

Generated: September 16, 2019

DrugPatentWatch Database Preview

Patent: 7,470,687

  Try a free trial

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,470,687
Title:Aryl oximes
Abstract: Aryl oxime derivatives of the formula (I), in which R.sup.1, R.sup.2, R.sup.3, X and B are as defined in Claim 1, act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS. ##STR00001##
Inventor(s): Eggenweiler; Hans-Michael (Darmstadt, DE), Beier; Norbert (Reinheim, DE), Schelling; Pierre (Muhltal, DE), Wolf; Michael (Darmstadt, DE)
Assignee: Merck Patent GmbH (Darmstadt, DE)
Application Number:11/429,181
Patent Claims:see list of patent claims

Details for Patent 7,470,687

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Advance Biofactures SANTYL collagenase VIAL 101995 001 1965-06-04   Try a Free Trial Merck Patent GmbH (Darmstadt, DE) 2022-06-10 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.